Mock James M

Chief Financial Officer | Please See Remarks

2 companies

Excellent

Trades Analyzed

12M Win Rate

100.0%

Avg 3M Return

+20.4%

Avg 12M Return

+60.2%

Mock James M is a Chief Financial Officer at Moderna, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 10 sells.

Estimated insider holdings value: $4.9M based on current market prices.

Holdings by Company

MRNAJan 5, 2026

Current Shares43.9K

Value$2.13M

Net Activity-10,811

Bought: 0Sold: 10.8K

RVTYJun 24, 2022

Current Shares27.6K

Value$2.73M

Net Activity-16,728

Bought: 0Sold: 16.7K

Showing 10 filings

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Nov 29, 2024	MRNA Moderna, Inc.	Chief Financial Officer	Sale+OE	1,420	$42.79	$60,760.52	-11.4%	-27.8%	-39.7%
Oct 7, 2024	MRNA Moderna, Inc.	Chief Financial Officer	Sale+OE	715	$60.12	$42,985.80	-7.0%	-27.5%	-53.4%
Aug 29, 2024	MRNA Moderna, Inc.	Chief Financial Officer	Sale+OE	162	$78.03	$12,640.21	-1.8%	-44.1%	-69.0%
Aug 28, 2024	MRNA Moderna, Inc.	Chief Financial Officer	Sale+OE	1,321	$79.39	$104,880.66	-13.3%	-46.3%	-68.8%
Jul 8, 2024	MRNA Moderna, Inc.	Chief Financial Officer	Sale+OE	689	$118.24	$81,465.36	-8.7%	-49.6%	-72.1%
Jun 3, 2024	MRNA Moderna, Inc.	Chief Financial Officer	Sale+OE	691	$140.72	$97,237.38	-9.6%	-50.7%	-81.2%
May 29, 2024	MRNA Moderna, Inc.	Chief Financial Officer	Sale+OE	183	$144.50	$26,444.36	-3.0%	-46.6%	-81.8%
May 28, 2024	MRNA Moderna, Inc.	Chief Financial Officer	Sale+OE	648	$162.47	$105,282.89	-10.2%	-46.7%	-83.0%
Apr 8, 2024	MRNA Moderna, Inc.	Chief Financial Officer	Sale+OE	705	$101.93	$71,859.31	-12.3%	+10.8%	-76.6%
Feb 29, 2024	MRNA Moderna, Inc.	Chief Financial Officer	Sale+OE	647	$94.57	$61,188.08	-13.1%	+60.4%	-66.4%